Advanced in Hereditary Hemorrhagic Telangiectasia

Christian Lavigne

CHU D'Angers
Angers, FR 
Advanced in Hereditary Hemorrhagic Telangiectasia
CHU D'Angers
Angers, FR 
OverviewLocationsClinical Research

Overview

Christian Lavigne practices in Angers, France. Mr. Lavigne is rated as an Advanced expert by MediFind in the treatment of Hereditary Hemorrhagic Telangiectasia. His top areas of expertise are Pernicious Anemia, Homocystinuria due to MTHFR Deficiency, Hereditary Hemorrhagic Telangiectasia, Splenectomy, and Kidney Transplant.

His clinical research consists of co-authoring 113 peer reviewed articles and participating in 4 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 9 articles and participated in 1 clinical trial in the study of Hereditary Hemorrhagic Telangiectasia.

Gender
Male

Locations

CHU d'Angers
Angers, 49933, France

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

4 Clinical Trials

Efficacy of Nintedanib Per os as a Treatment for Epistaxis in HHT Disease. A National, Randomized, Multicentre Phase II Study
Efficacy of Nintedanib Per os as a Treatment for Epistaxis in HHT Disease. A National, Randomized, Multicentre Phase II Study
Enrollment Status: Completed
Publish Date: August 01, 2025
Intervention Type: Drug
Study Drug: Nintedanib
Study Phase: Phase 2
Treatment-related Benefit and Satisfaction in Fabry Patients. Insight in Patients Expectations and Preferences (SATIS-Fab)
Treatment-related Benefit and Satisfaction in Fabry Patients. Insight in Patients Expectations and Preferences (SATIS-Fab)
Enrollment Status: Completed
Publish Date: May 23, 2024
Intervention Type: Behavioral
Glytactin EfficiEncy in Non or Insufficiently Treated Adult PHENylketonuria Patients
Glytactin EfficiEncy in Non or Insufficiently Treated Adult PHENylketonuria Patients
Enrollment Status: Completed
Publish Date: September 21, 2022
Intervention Type: Dietary supplement
Study Phase: Not Applicable
Pharmacoepidemiology Treatment of Symptomatic Pulmonary Embolism in Hospitalized Patients Aged 75 Years or More: Prospective, Multicenter Cohort Study PEAGE
Pharmacoepidemiology Treatment of Symptomatic Pulmonary Embolism in Hospitalized Patients Aged 75 Years or More: Prospective, Multicenter Cohort Study PEAGE
Enrollment Status: Completed
Publish Date: August 25, 2022
Intervention Type: Other
View 3 Less Clinical Trials

113 Total Publications

Challenges and issues for better understanding and recognition of French internal medicine
Challenges and issues for better understanding and recognition of French internal medicine
Journal: La Revue de medecine interne
Published: November 25, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Lavigne's expertise for a condition
ConditionClose
    View All 18 Advanced Conditions
    View All 68 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile